Patents by Inventor Stephen A. Goff

Stephen A. Goff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030135888
    Abstract: The invention provides a method to identify genes that are modulated by posttranscriptional gene silencing as well as regulatory elements and methods to modulate gene expression by posttranscriptional gene silencing.
    Type: Application
    Filed: September 26, 2002
    Publication date: July 17, 2003
    Inventors: Tong Zhu, Xun Wang, Hur-Song Chang, Steven P. Briggs, Bret Cooper, Jane Glazebrook, Stephen A. Goff, Fumiaki Katagiri, Joel Kreps, Todd Moughamer, Nicholas Provart, Darrell Ricke
  • Publication number: 20030032028
    Abstract: A method is disclosed for capturing one or more target sequences utilizing modified, high stringency nucleic acids and strand displacement stategies. In this method, one or more modified, high stringency oligonucleotide (MHSO) conjugates are selected in which the conjugates are constructed from at least one modified nucleic acid, such as, for example, a locked nucleic acid (“LNA”) and a linking molecule. When incubated with a sample of nucleic acids, these MHSO conjugates capture the target sequence by selectively binding to complementary sequences of DNA or RNA, which may be either single or double stranded. Once bound, the resulting complexes constitute hybridized duplexes containing both a targeted sequence portion and a MHSO conjugate portion. The captured target sequences are separated from the sample by using a linking source that binds to the linking molecule of the hybridized duplex and extracting the linking source with the bound duplex from the sample.
    Type: Application
    Filed: February 15, 2002
    Publication date: February 13, 2003
    Inventors: Gayle Dace, William Kimmerly, Stephen Goff, Paul Oeller
  • Publication number: 20010022004
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3′ termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3′ termination region.
    Type: Application
    Filed: March 21, 2001
    Publication date: September 13, 2001
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 6147282
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: November 14, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 5880333
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: March 9, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 4758512
    Type: Grant
    Filed: March 6, 1984
    Date of Patent: July 19, 1988
    Assignee: President and Fellows of Harvard College
    Inventors: Alfred L. Goldberg, Stephen A. Goff, Lawrence P. Casson